Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis
- 1 August 2001
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 64 (2) , 125-133
- https://doi.org/10.1016/s0010-7824(01)00234-7
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Interpretations. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risksHuman Reproduction Update, 1999
- Gestodene, Desogestrel, and Venous Thromboembolism: A Little Risk after a Long LookJournal of Clinical Endocrinology & Metabolism, 1999
- The epidemiology of oral contraceptive use: A critical review of the studies on oral contraceptives and the health of young womenAmerican Journal of Obstetrics and Gynecology, 1998
- Bias versus causality: Interpreting recent evidence of oral contraceptive studiesAmerican Journal of Obstetrics and Gynecology, 1998
- Developments in contraception: a comprehensive review of Desogen® (desogestrel and ethinyl estradiol)Contraception, 1998
- Newer Oral Contraceptives and the Risk of Venous ThromboembolismContraception, 1998
- Basic Methods for Sensitivity Analysis of BiasesInternational Journal of Epidemiology, 1996
- Gestodene-Containing ContraceptivesClinical Obstetrics and Gynecology, 1995
- Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-AnalysisAmerican Journal of Epidemiology, 1992
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986